TipRanks on MSN

C4 Therapeutics Announces Stock and Warrants Offering

C4 Therapeutics ( ($CCCC) ) has shared an update. On October 16, 2025, C4 Therapeutics announced an underwritten offering of common stock and ...

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

Concurrent with the proposed public offering, Lexeo intends to sell shares of its common stock, and, in lieu of common stock, pre-funded warrants to purchase shares of its common stock, to Balyasny ...

Dragonfly Energy Announces Pricing of $55.4 Million Public Offering of Common Stock and Pre-Funded Warrants

Canaccord Genuity is acting as the sole bookrunner for the offering. Roth Capital Partners is acting as co-manager for the offering.
TipRanks on MSN

Hyperfine announces offering of Class A common stock, warrants, no amount given

Hyperfine (HYPR) announced that it has commenced an underwritten public offering of its Class A common stock or, in lieu of Class A common stock ...

Jim Cramer Shares Key Insights About IonQ’s (IONQ) $2 Billion Offering

We recently published Jim Cramer Discussed These 11 Stocks & The Market’s 3rd Bull Run Anniversary. IonQ, Inc. (NYSE:IONQ) is ...

Dragonfly Energy Shares Drop After $55.4M Public Offering Prices

Dragonfly Energy shares were 30% lower, at $1.38, after the company priced an underwritten public offering of 36 million shares at $1.35 a share and prefunded warrants to buy up to 5 million shares at ...

EyePoint prices public offering at $12.00 per share, raises $150M to boost DURAVYU™ Phase 3 clinical programs

EyePoint Pharmaceuticals (EYPT) has announced the pricing of a significant underwritten public offering expected to generate approximately $150 million in gross proceeds. The capital raise is primaril ...

D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering

NEW YORK CITY, NEW YORK / ACCESS Newswire / October 14, 2025 / On October 7, 2025, Humacyte, Inc. (Nasdaq:HUMA), a commercial-stage biotechnology platform company developing universally implantable, ...
The Manila Times

Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...
Investing.com Canada

Lexeo Therapeutics stock falls after announcing public offering

Investing.com -- Lexeo Therapeutics Inc (NASDAQ:LXEO) stock dropped 4.7% in after-hours trading Thursday following the company’s announcement of a proposed public offering and concurrent private ...
The Manila Times

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Financing led by Samsara BioCapital, L.P. ('Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds,Invus and Mr. Mir ImranAt the ...

Largo Shares Fall on Pricing for Share Offering

Shares of Largo were lower Wednesday morning after setting the pricing for its $23.4 million offering. Stock trading in Toronto fell 45% to 1.92 Canadian dollars ($1.37) and was down 46% in New York ...